miRNAs Flowing Up and Down: The Concerto of Psoriasis

Yang Xiuli1, Wang Honglin1

  • 1Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Translational Medicine Center, Shanghai Institute of Immunology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in Medicine
|March 15, 2021
PubMed

Insights

Dysregulated microRNAs (miRNAs) contribute to psoriasis by affecting skin cell proliferation and immune cell balance. These molecular players, including miR-31 and miR-125b, are key targets for understanding and treating this chronic skin condition.

Area of Science:

  • Dermatology
  • Immunology
  • Molecular Biology

Background:

  • Psoriasis is a chronic immune-mediated skin disease.
  • Hallmarks include keratinocyte hyperproliferation and CD4+ T cell imbalance.
  • Dysregulated microRNAs (miRNAs) are implicated in psoriasis pathogenesis.

Purpose of the Study:

  • To review dysregulated miRNAs contributing to psoriasis hallmarks.
  • To focus on confirmed miRNA target genes.
  • To explore miRNA roles in keratinocyte and T cell functions.

Main Methods:

  • Literature review of studies on miRNAs in psoriasis.
  • Analysis of miRNA networks and their target genes.
  • Focus on specific upregulated and downregulated miRNAs.

Main Results:

  • Upregulated miRNAs (miR-31, miR-203, miR-155, miR-21) and downregulated miRNAs (miR-99a, miR-125b) affect keratinocyte proliferation and differentiation.
  • Upregulated miR-210 and downregulated miR-138 impact CD4+ T cell subset balance.
  • These miRNAs regulate key transcription factors like NF-κB and STAT3.

Conclusions:

  • Dysregulated miRNAs, both up and down, collaborate in psoriasis development and maintenance.
  • Targeting these miRNAs offers potential therapeutic strategies for psoriasis.
  • Understanding miRNA networks is crucial for unraveling psoriasis mechanisms.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.5K